Dompé agrees to pay $32 million over Medicare co-pay allegations
Dompé will pay $32 million plus interest to resolve DOJ allegations involving foundation-funded Medicare co-pays for its Oxervate eye treatment.
Pharmaceuticals
-
-
India’s U.S. trade framework faces a new tariff test
A final U.S. 10% tariff action has changed India’s trade position while negotiators work toward a broader agreement that remains unfinished.
-
U.S. Pharmaceutical Tariffs Take Effect July 31: What Changes
Tariffs on some imported patented drugs begin July 31, but generic medicines and biosimilars remain excluded as companies face different rates and deadlines.
-
U.S. trade probe into Germany’s drug pricing revives transatlantic tariff risk
World Economy Trade Energy and Technology Scan – USTR opened a Section 301 probe into Germany’s drug pricing, a step that could escalate into tariff pressure.